Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure
- 4 September 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Molecular Medicine
- Vol. 88 (10), 1011-1020
- https://doi.org/10.1007/s00109-010-0679-1
Abstract
Right ventricular failure (RVF) is the leading cause of death in pulmonary arterial hypertension (PAH). Some patients with pulmonary hypertension are adaptive remodelers and develop RV hypertrophy (RVH) but retain RV function; others are maladaptive remodelers and rapidly develop RVF. The cause of RVF is unclear and understudied and most PAH therapies focus on regressing pulmonary vascular disease. Studies in animal models and human RVH suggest that there is reduced glucose oxidation and increased glycolysis in both adaptive and maladaptive RVH. The metabolic shift from oxidative mitochondrial metabolism to the less energy efficient glycolytic metabolism may reflect myocardial ischemia. We hypothesize that in maladaptive RVH a vicious cycle of RV ischemia and transcription factor activation causes a shift from oxidative to glycolytic metabolism thereby ultimately promoting RVF. Interrupting this cycle, by reducing ischemia or enhancing glucose oxidation, might be therapeutic. Dichloroacetate, a pyruvate dehydrogenase kinase inhibitor, has beneficial effects on RV function and metabolism in experimental RVH, notably improving glucose oxidation and enhancing RV function. This suggests the mitochondrial dysfunction in RVH may be amenable to therapy. In this mini review, we describe the role of impaired mitochondrial metabolism in RVH, using rats with adaptive (pulmonary artery banding) or maladaptive (monocrotaline-induced pulmonary hypertension) RVH as models of human disease. We will discuss the possible mechanisms, relevant transcriptional factors, and the potential of mitochondrial metabolic therapeutics in RVH and RVF.Keywords
This publication has 56 references indexed in Scilit:
- Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis inductionJCI Insight, 2010
- The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricleJournal of Molecular Medicine, 2009
- Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen speciesCardiovascular Research, 2007
- Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointesEP Europace, 2007
- Hypertrophic growth in cardiac myocytes is mediated by Myc through a Cyclin D2-dependent pathwayThe EMBO Journal, 2006
- Ranolazine Improves Abnormal Repolarization and Contraction in Left Ventricular Myocytes of Dogs with Heart Failure by Inhibiting Late Sodium CurrentJournal of Cardiovascular Electrophysiology, 2006
- Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failurePhysiological Genomics, 2005
- Expression and regulation of pyruvate dehydrogenase kinase isoforms in the developing rat heart and in adulthood: role of thyroid hormone status and lipid supplyBiochemical Journal, 2000
- Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventionsCardiovascular Research, 1997
- The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations.Circulation, 1981